Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: pegylated liposomal doxorubicin hydrochloride|DRUG: docetaxel|BIOLOGICAL: trastuzumab|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)